GB5121 is a novel highly potent and selective CNS-penetrant BTK inhibitor for CNS malignanciesIsharat Yusuf,Sunil Sahdeo,Taylor Ismaili, Zachary Naiman, David Guimond, Theodore Schiff,Bryan Clemons, Krystal Herman, Bryanna Paulson,Kay Hou,Kristen Taylor Meadows,Michael Kennedy,Mark Rose,Laura CarterCANCER RESEARCH(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要